Clinical relevance of findings in trials of antipsychotics: systematic review
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: There is concern over the methods used to evaluate antipsychotic drugs. Aims: To assess the clinical relevance of findings in the literature. Method: A systematic review identified studies of antipsychotics that used the Brief Psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS). A published method of translating these into Clinical Global Impression – Change scale (CGI–C) scores was used to measure clinical relevance. Results: In total 98 data-sets were included in the BPRS analysis and 202 data-sets in the PANSS analysis. When aggregated scores were translated into notional CGI–C scores, most drugs reached ‘minimal improvement’ on the BPRS, but few reached that level for PANSS. This was true of both first- and second-generation drugs, including clozapine. Amisulpride and olanzapine had better than average CGI–C scores. Conclusions: Our findings show improvements of limited clinical relevance. The CGI–C scores were better for the BPRS than for the PANSS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Csernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002028 · Cited by 605
Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Kumra, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120020005 · Cited by 410
McEvoy, J. P., Lieberman, J. A., Perkins, D. O., Hamer, R. M., Gu, H., Lazarus, A., Sweitzer, D., Olexy, C., Weiden, P., & Strakowski, S. D. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1050 · Cited by 377
Standardized remission criteria in schizophrenia
van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Bernardo, M., Arango, C., Fleischhacker, W., Lachaux, B., et al. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00659.x · Cited by 285
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
Honer, W. G., Thornton, A. E., Chen, E. Y. H., Chan, R. C. K., Wong, J. O. Y., Bergmann, A., Falkai, P., Pomarol-Clotet, E., McKenna, P. J., Stip, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053222 · Cited by 277
Cited by
Psychiatry beyond the current paradigm
Bracken, P., Thomas, P., Timimi, S., Asen, E., Behr, G., Beuster, C., Bhunnoo, S., Browne, I., Chhina, N., Double, D., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.109447 · Cited by 474
Emerging perspectives from the hearing voices movement: implications for research and practice
Corstens, D., Longden, E., McCarthy-Jones, S., Waddingham, R., & Thomas, N. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu007 · Cited by 256
“eradication is typically not reliably achieved—neither by psychosocial interventions (Thomas et al, this issue) nor by pharmacotherapy.(46) Being able to experience voice-hearing with reduced negative impact on subjec-”
BackgroundLeucht, S., Fennema, H., Engel, R., Kaspers–Janssen, M., Lepping, P., & Szegedi, A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.001 · Cited by 211
Self-citationRead, J., & Williams, J. (2019) · Current Drug Safety · doi:10.2174/1574886314666190301152734 · Cited by 80
Clinical relevance of findings in trials of CBT for depression
Lepping, P., Whittington, R., Sambhi, R. S., Lane, S., Poole, R., Leucht, S., Cuijpers, P., McCabe, R., & Waheed, W. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.07.003 · Cited by 60
“The same or similar methods have been used to evaluate clinical relevance of antipsychotic trial data [8], transcranial magnetic stimulation trial data [15], antidepressant trial data [16], and cognitive therapies for schizophrenia trial data [17].”
MethodSelf-citationMetacognitive therapy in treatment-resistant psychosis: a multiple-baseline study.
Hutton, P., Morrison, A. P., Wardle, M., & Wells, A. (2014) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812001026 · Cited by 58
“…main pharmacological intervention, antipsychotic medication, provides a clinically meaningful benefit above placebo has recently been questioned (Lepping, Sambhi, Whittington, Lane and Poole, 2011; Leucht, Arbter, Engel, Kissling and Davis, 2009a; Rattehalli, Jayaram and Smith, 2010), while…”
BackgroundHow do hearing voices peer-support groups work? A three-phase model of transformation
Hornstein, G. A., Robinson Putnam, E., & Branitsky, A. (2020) · Psychosis · doi:10.1080/17522439.2020.1749876 · Cited by 26
Metadata
- Authors
- Lepping, P., Sambhi, R. S., Whittington, R., Lane, S., & Poole, R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2011-05
- Volume
- 198
- Issue
- 5
- Pages
- 341-345
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2135102484
- Cited by
- 80
- References
- 7
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.